In 2007, Choi and colleagues [2] showed that the absence of CCR1 and its interaction with its ligand (CCL5) was related to greater survival of the mice with GVHD, reduced clinical signs of the disease and the reduced production of proinflammatory cytokines. Here, CCL5 is linked to graft versus host disease.